• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: 'Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus' by Wang .

作者信息

Müller-Calleja Nadine, Lackner Karl J

机构信息

Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Mainz, Germany.

出版信息

Ann Rheum Dis. 2019 Aug;78(8):e81. doi: 10.1136/annrheumdis-2018-213853. Epub 2018 Jun 26.

DOI:10.1136/annrheumdis-2018-213853
PMID:29945922
Abstract
摘要

相似文献

1
Response to: 'Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus' by Wang .对王[等人]的《抗疟药对中国系统性红斑狼疮患者的保护作用》的回应
Ann Rheum Dis. 2019 Aug;78(8):e81. doi: 10.1136/annrheumdis-2018-213853. Epub 2018 Jun 26.
2
Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou .皮下注射贝利尤单抗与长期抗疟治疗联合应用可降低系统性红斑狼疮患者的抗磷脂抗体水平：一项随机安慰剂对照试验的事后分析——对Chatzidionysiou的“贝利尤单抗治疗对抗磷脂抗体水平的影响：基于两项系统性红斑狼疮随机安慰剂对照试验的事后分析”的评论
Ann Rheum Dis. 2022 Aug;81(8):e140. doi: 10.1136/annrheumdis-2020-218377. Epub 2020 Aug 4.
3
Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus.抗疟药对中国系统性红斑狼疮患者的保护作用。
Ann Rheum Dis. 2019 Aug;78(8):e80. doi: 10.1136/annrheumdis-2018-213819. Epub 2018 Jun 26.
4
Response to: 'Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou ' by Bettiol .对以下内容的回应：“皮下注射贝利尤单抗与长期抗疟治疗联合使用可降低系统性红斑狼疮患者的抗磷脂抗体水平：一项随机安慰剂对照试验的事后分析——评Chatzidionysiou等人的‘贝利尤单抗治疗对抗磷脂抗体水平的影响：基于两项系统性红斑狼疮随机安慰剂对照试验的事后分析’”，作者为Bettiol 。
Ann Rheum Dis. 2022 Aug;81(8):e141. doi: 10.1136/annrheumdis-2020-218444. Epub 2020 Aug 4.
5
Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.羟氯喹在系统性红斑狼疮及抗磷脂抗体阳性患者中预防血栓形成的应用。
Curr Rheumatol Rep. 2011 Feb;13(1):77-80. doi: 10.1007/s11926-010-0141-y.
6
Response to: 'Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus' by Wu .
Ann Rheum Dis. 2022 May;81(5):e76. doi: 10.1136/annrheumdis-2020-217804. Epub 2020 May 20.
7
Antimalarial agents and lupus.抗疟药与狼疮
Rheum Dis Clin North Am. 1994 Feb;20(1):243-63.
8
Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo .对近藤所著《系统性红斑狼疮患者中由COVID-19引发的免疫性血小板减少症恶化》的回应
Ann Rheum Dis. 2021 May;80(5):e78. doi: 10.1136/annrheumdis-2020-218176. Epub 2020 Aug 5.
9
NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus.NCF1-339 多态性与中性粒细胞胞外诱捕网形成改变、高血清干扰素活性和系统性红斑狼疮中的抗磷脂综合征有关。
Ann Rheum Dis. 2020 Feb;79(2):254-261. doi: 10.1136/annrheumdis-2019-215820. Epub 2019 Nov 8.
10
Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.母胎医学会咨询系列第 64 号：妊娠合并系统性红斑狼疮。
Am J Obstet Gynecol. 2023 Mar;228(3):B41-B60. doi: 10.1016/j.ajog.2022.09.001. Epub 2022 Sep 6.